Nemaura Medical Inc. NMRD shares are trading higher after the company receipt of a purchase order for 5,000 sugarBEAT transmitters and 200,000 sugarBEAT sensors from its U.K. licensee, DB Ethitronix Ltd.
The company also announced there is an additional rolling monthly purchase order forecast for the next 24 months of 15,000 transmitters and 2.1 million sensors, with an option to increase volumes based on customer response.
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices.
Nemaura Medical's stock closed up 135% at $11.06. The stock has a 52-week high of $16.50 and a 52-week low of $3.12.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
